T-cell activation by recombinant immunoreceptors: Impact of the intracellular signalling domain on the stability of receptor expression and antigen-specific activation of grafted T cells
- 1 August 2003
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 10 (17) , 1408-1419
- https://doi.org/10.1038/sj.gt.3302023
Abstract
Recombinant immunoreceptors are modularily composed of extracellular antigen binding and intracellular signalling domains that are preferentially derived from CD3 or FcRI. The impact of the signalling domain on the stability of immuoreceptor expression and function is not completely understood. To address this issue, we generated and expressed a panel of recombinant - and -chain immunoreceptors, respectively, in human peripheral blood T cells. The expression level of -chain immunoreceptors in human T cells is significantly lower than those of the homologous -chain receptors. Low -chain receptor expression in peripheral T cells is because of the intracellular signalling domain and independent of the FcRI or CD3 transmembrane region. Expression of both receptors decreases upon prolonged cultivation. Shortly after receptor engraftment, target cell lysis and induction of IFN- secretion are mediated with similar efficiency by - and -chain immunoreceptors. Upon prolonged propagation, however, T-cell activation mediated by -chain immunoreceptors is more efficient than by -chain receptors, indicating that the initial high expression level of -chain immunoreceptors compensates its lower activation capacity. Consequently, -chain immunoreceptors exhibit a higher threshold value for specific activation and are more pronouncedly inhibited by soluble ligand antigen compared to the homologous -chain receptor. These findings have substantial consequences for the design of recombinant immunoreceptors for use in adoptive immunotherapy.Keywords
This publication has 25 references indexed in Scilit:
- Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptorNature Biotechnology, 2002
- T cell activation by recombinant FcεRI γ-chain immune receptors: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognitionGene Therapy, 2000
- Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine productionGene Therapy, 2000
- Impact of chimeric immune receptor extracellular protein domains on T cell functionGene Therapy, 1999
- A retroviral vector system ‘STITCH’ in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytesGene Therapy, 1998
- Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells?Immunology Today, 1998
- Different roles for the Fc epsilon RI gamma chain as a function of the receptor context.The Journal of Experimental Medicine, 1995
- Transmembrane signalling through the T-cell-receptor-CD3 complexCurrent Opinion in Immunology, 1993
- Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cellsJournal of Immunological Methods, 1992
- Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptidesCell, 1991